GlassScriptPhysician profile
Edward Cohen
NPI 1093756827
$20,781.32
in general payments reported to CMS, 2019-2025
65 companies · $3,017 in 2025
The $3,017 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,617 · 2020: $4,666 · 2021: $4,037 · 2022: $1,941 · 2023: $901 · 2024: $1,601 · 2025: $3,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,097 · Consulting Fee: $1,388 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,097.30 |
| Consulting Fee | $1,387.50 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $3,267.92 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,847.55 | 2019-2024 | |
| Janssen Biotech, INC. | $2,803.64 | 2019-2025 | Erleada, Akeega, Rybrevant |
| Genzyme Corporation | $2,191.74 | 2020 | |
| Abbvie INC. | $1,117.19 | 2019-2025 | Lupron Depot, Botox |
| Dendreon Pharmaceuticals LLC | $1,076.21 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $529.89 | 2021-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $521.71 | 2019-2023 | Xiaflex |
| Coloplast Corp | $452.80 | 2019-2023 | Speedicath |
| Astellas Pharma US INC | $382.87 | 2019-2022 | |
| Myovant Sciences INC. | $342.07 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $313.35 | 2019-2025 | Keytruda, Lynparza |
| Laborie Medical Technologies Corp. | $307.47 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $285.11 | 2020-2025 | Imfinzi |
| Ferring Pharmaceuticals INC. | $249.45 | 2019-2025 | Adstiladrin |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.